Wild C, Weiderpass E, Stewart BW (Eds.) (2020) World cancer report: cancer research for cancer prevention. IARC Press.
Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. Biomark Med. 2013;7(1):49–58.
Begum S, Brait M, Dasgupta S, et al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res. 2011;17(13):4494–503.
Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking. BMJ. 1956;2(5001):1071.
Hecht SS. Tobacco smoke carcinogens and lung cancer. JNCI J Natl Cancer Inst. 1999;91(14):1194–210.
Guida F, Sandanger TM, Castagné R, et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum Mol Genet. 2015;24(8):2349–59. https://doi.org/10.1093/hmg/ddu751.
Maas SC, Vidaki A, Wilson R, et al. Validated inference of smoking habits from blood with a finite DNA methylation marker set. Eur J Epidemiol. 2019;34(11):1055–74.
Brothers JF, Hijazi K, Mascaux C, El-Zein RA, Spitz MR, Spira A. Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-national lung screening trial era. BMC Med. 2013;11(1):168.
Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci. 2004;101(27):10143–8.
Teschendorff AE, Yang Z, Wong A, et al. Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer. JAMA Oncol. 2015;1(4):476–85.
Baglietto L, Ponzi E, Haycock P, et al. DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. Int J Cancer. 2017;140(1):50–61. https://doi.org/10.1002/ijc.30431.
Fasanelli F, Baglietto L, Ponzi E, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015;6:10192. https://doi.org/10.1038/ncomms10192.
Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect. 2014;122(2):131–7. https://doi.org/10.1289/ehp.1306937.
Dugué P-A, Jung C-H, Joo JE, et al. Smoking and blood DNA methylation: an epigenome-wide association study and assessment of reversibility. Epigenetics. 2020;15(4):358–68. https://doi.org/10.1080/15592294.2019.1668739.
Zhao N, Ruan M, Koestler DC, et al. Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood. Epigenetics. 2021;1–13.
Lund E, Dumeaux V, Braaten T, et al. Cohort profile: the Norwegian women and cancer study—NOWAC—Kvinner og kreft. Int J Epidemiol. 2007;37(1):36–41.
Dumeaux V, Børresen-Dale A-L, Frantzen J-O, Kumle M, Kristensen VN, Lund E. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res. 2008;10(1):R13.
Chadeau-Hyam M, Vermeulen R, Hebels D, et al. Prediagnostic transcriptomic markers of chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis. Ann Oncol. 2014;25(5):1065–72.
McHale CM, Zhang L, Lan Q, et al. Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect. 2011;119(5):628–40.
Joehanes R, Just Allan C, Marioni Riccardo E, et al. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet. 2016;9(5):436–47. https://doi.org/10.1161/CIRCGENETICS.116.001506.
Remen T, Pintos J, Abrahamowicz M, Siemiatycki J. Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal. BMC Cancer. 2018;18(1):1275. https://doi.org/10.1186/s12885-018-5144-5.
Chadeau-Hyam M, Campanella G, Jombart T, et al. Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagen. 2013;54(7):542–57.
Peters TJ, Buckley MJ, Statham AL, et al. De novo identification of differentially methylated regions in the human genome. Epigenet Chromatin. 2015;8(1):6. https://doi.org/10.1186/1756-8935-8-6.
Meinshausen N, Bühlmann P. Stability selection. J R Stat Soc Ser B. 2010;72(4):417–73.
Bodinier B, Filippi S, Nost TH, Chiquet J, Chadeau-Hyam M. Automated calibration for stability selection in penalised regression and graphical models: a multi-OMICs network application exploring the molecular response to tobacco smoking. arxiv. 2021.
Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 2012;13(1):86.
Battram T, Richmond RC, Baglietto L, et al. Appraising the causal relevance of DNA methylation for risk of lung cancer. Int J Epidemiol. 2019;48(5):1493–504. https://doi.org/10.1093/ije/dyz190.
Sandanger TM, Nøst TH, Guida F, et al. DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian women and cancer cohort. Sci Rep. 2018;8(1):1–10.
Chen Z, Xiong S, Li J, et al. DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model. Transl Lung Cancer Res. 2020;9(2):280–7. https://doi.org/10.21037/tlcr.2020.03.13.
He R, Zuo S. A robust 8-gene prognostic signature for early-stage non-small cell lung cancer. Front Oncol. 2019;9:693. https://doi.org/10.3389/fonc.2019.00693.
Sehovic E, Hadrovic A, Dogan S. Detection and analysis of stable and flexible genes towards a genome signature framework in cancer. Bioinformation. 2019;15(10):772–9. https://doi.org/10.6026/97320630015772.
Fei L-R, Huang W-J, Wang Y, et al. PRDM16 functions as a suppressor of lung adenocarcinoma metastasis. J Exp Clin Cancer Res. 2019;38(1):35. https://doi.org/10.1186/s13046-019-1042-1.
Hu C, Zhang Q, Tang Q, et al. CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer. J Cell Mol Med. 2020;24(1):618–31.
Muscarella LA, D’Alessandro V, la Torre A, et al. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients. Cell Oncol. 2011;34(5):435–41. https://doi.org/10.1007/s13402-011-0025-9.
Saha B, Gil C. High expression of TTYH3 is related to poor clinical outcomes in human gastric cancer. J Clin Med. 2019;8(11):1762. https://doi.org/10.3390/jcm8111762.
Bisgaard H. Persistent wheezing in very young preschool children reflects lower respiratory inflammation. Am J Respir Crit Care Med. 2001;163(6):1290–1. https://doi.org/10.1164/ajrccm.163.6.ed1801b.
Morales E, Bustamante M, Vilahur N, et al. DNA hypomethylation at ALOX12 is associated with persistent wheezing in childhood. Am J Respir Crit Care Med. 2012;185(9):937–43. https://doi.org/10.1164/rccm.201105-0870OC.
Natarajan R, Esworthy R, Bai W, Gu J-L, Wilczynski S, Nadler J. Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor. J Clin Endocrinol Metab. 1997;82(6):1790–8.
Stephen R, Crabtree J, Yoshimura T, Clayton C, Dixon M, Robinson P. Increased zinc finger protein zFOC1 transcripts in gastric cancer compared with normal gastric tissue. Mol Pathol. 2003;56(3):167.
Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. 2016;54(1):1–30.
Fawdar S, Trotter EW, Li Y, et al. Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer. Proc Natl Acad Sci. 2013;110(30):12426–31.
Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017. https://doi.org/10.1126/science.aan2507.
Wang S, Bian C, Yang Z, et al. miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol. 2009;34(5):1461–6.
Li W, Li J-F, Qu Y, et al. Comparative proteomics analysis of human gastric cancer. World J Gastroenterol WJG. 2008;14(37):5657–64. https://doi.org/10.3748/wjg.14.5657.
Feng F, Huang L, Zhou G, Wang J, Zhang R, Li Z, Zhang Y, Ba Y. GPR61 methylation in cord blood: a potential target of prenatal exposure to air pollutants. Int J Environ Health Res. 2020;32(2):463–72. https://doi.org/10.1080/09603123.2020.1773414.
He W, Lu J. MiR-338 regulates NFATc1 expression and inhibits the proliferation and epithelial-mesenchymal transition of human non-small-cell lung cancer cells. Mol Genet Genomic Med. 2020;8(2):e1091. https://doi.org/10.1002/mgg3.1091.
Xian H, Li Y, Zou B, et al. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis. BMC Cancer. 2022;22(1):1–17.
Ping M, Wang S, Chen Y, Jia J. The short non-coding RNA 1251–5p regulates stemness transformation and inhibits aggression of lung malignant tumor cells. J Biomater Tissue Eng. 2021;11(5):982–9.
Thomas PD, Campbell MJ, Kejariwal A, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003;13(9):2129–41. https://doi.org/10.1101/gr.772403.
Marek L, Ware KE, Fritzsche A, et al. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells. Mol Pharmacol. 2009;75(1):196–207.
Caccavari F, Valdembri D, Sandri C, Bussolino F, Serini G. Integrin signaling and lung cancer. Cell Adh Migr. 2010;4(1):124–9.
Mazieres J, He B, You L, Xu Z, Jablons DM. Wnt signaling in lung cancer. Cancer Lett. 2005;222(1):1–10.
Bae G-Y, Choi S-J, Lee J-S, et al. Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget. 2013;4(12):2512.
Herbst RS, Onn A, Sandler A. Angiogenesis and lung cancer: prognostic and therapeutic implications. J Clin Oncol. 2005;23(14):3243–56.
Lu C, Huang T, Chen W, Lu H. GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway. Oncol Rep. 2015;34(1):244–50.
Yun H, Park M, Kim D, et al. Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development. Oncogene. 2014;33(44):5193–200.
Logue MW, Smith AK, Wolf EJ, et al. The correlation of methylation levels measured using Illumina 450K and EPIC BeadChips in blood samples. Epigenomics. 2017;9(11):1363–71.